Agency Forms Undergoing Paperwork Reduction Act Review

Download PDF
Federal RegisterSep 20, 2017
82 Fed. Reg. 43985 (Sep. 20, 2017)

The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. CDC previously published a “Proposed Data Collection Submitted for Public Comment and Recommendations” notice on May 30, 2017 to obtain comments from the public and affected agencies. CDC received one comment related to the first notice. The purpose of this notice is to allow an additional 30 days for public comments.

Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. The Office of Management and Budget is particularly interested in comments that:

(a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;

(b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;

(c) Enhance the quality, utility, and clarity of the information to be collected;

(d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and

(e) Assess information collection costs.

To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639-7570 or send an email to omb@cdc.gov. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW., Washington, DC 20503 or by fax to (202) 395-5806. Provide written comments within 30 days of notice publication.

Proposed Project

National Healthcare Safety Network (NHSN) (OMB No. 0920-0666), exp. 11/30/2019—Revision—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

The National Healthcare Safety Network (NHSN) is a system designed to accumulate, exchange, and integrate relevant information and resources among private and public stakeholders to support local and national efforts to protect patients and promote healthcare safety. Specifically, CDC uses the data to determine the magnitude of various healthcare-associated adverse events and trends in the rates of these events among patients and healthcare workers with similar risks. CDC will use the data to detect changes in the epidemiology of adverse events resulting from new and current medical therapies and changing risks.

The NHSN currently consists of five components: Patient Safety, Healthcare Personnel Safety, Biovigilance, Long-Term Care Facility (LTCF), and Dialysis. CDC will release the NHSN “Outpatient Procedure Component” in 2018. CDC's request for additional user feedback and support from outside partners delayed development of this component.

After receiving user feedback and internal review feedback, CDC made changes to six facility surveys. For the annual facility surveys, CDC amended, removed, or added questions and response options to fit the survey's evolving uses. In addition, CDC and its partners use the surveys to help intelligently interpret the other data elements reported into NHSN. Currently, the surveys are used to appropriately risk adjust the numerator and denominator data entered into NHSN while also guiding decisions on future division priorities for prevention.

Further, two new forms were added to expand NHSN surveillance to enhance data collection by Ambulatory Surgical Centers to identify areas where prevention of SSIs may be improved. CDC modified an additional 14 forms within the Hemovigilance module to streamline data collection/entry for adverse reaction events.

Overall, CDC has made minor revisions to a total of 44 forms within the package to clarify and/or update surveillance definitions, increase or decrease the number of reporting facilities, and adding 2 new forms. The previously approved NHSN information collection package included 70 individual collection forms; the current revision request includes 72 forms. The reporting burden will increase by 811,985 hours, for a total of 5,922,953 hours.

Estimated Annualized Burden Hours

Type of respondent Form No. & name Number of respondents Number of responses per respondent Average burden per response (hours)
Registered Nurse (Infection Preventionist) 57.100 NHSN Registration Form 2,000 1 5/60
Registered Nurse (Infection Preventionist) 57.101 Facility Contact Information 2,000 1 10/60
Registered Nurse (Infection Preventionist) 57.103 Patient Safety Component—Annual Hospital Survey 5,000 1 55/60
Registered Nurse (Infection Preventionist) 57.105 Group Contact Information 1,000 1 5/60
Registered Nurse (Infection Preventionist) 57.106 Patient Safety Monthly Reporting Plan 6,000 12 15/60
Registered Nurse (Infection Preventionist) 57.108 Primary Bloodstream Infection (BSI) 6,000 44 30/60
Registered Nurse (Infection Preventionist) 57.111 Pneumonia (PNEU) 6,000 72 30/60
Registered Nurse (Infection Preventionist) 57.112 Ventilator-Associated Event 6,000 144 25/60
Registered Nurse (Infection Preventionist) 57.113 Pediatric Ventilator-Associated Event (PedVAE) 2,000 120 25/60
Registered Nurse (Infection Preventionist) 57.114 Urinary Tract Infection (UTI) 6,000 40 20/60
Registered Nurse (Infection Preventionist) 57.115 Custom Event 2,000 91 35/60
Staff RN 57.116 Denominators for Neonatal Intensive Care Unit (NICU) 6,000 12 4
Staff RN 57.117 Denominators for Specialty Care Area (SCA)/Oncology (ONC) 6,000 9 5
Staff RN 57.118 Denominators for Intensive Care Unit (ICU)/Other locations (not NICU or SCA) 6,000 60 5
Registered Nurse (Infection Preventionist) 57.120 Surgical Site Infection (SSI) 6,000 36 35/60
Staff RN 57.121 Denominator for Procedure 6,000 540 10/60
Laboratory Technician 57.123 Antimicrobial Use and Resistance (AUR)—Microbiology Data Electronic Upload Specification Tables 6,000 12 5/60
Pharmacist 57.124 Antimicrobial Use and Resistance (AUR)—Pharmacy Data Electronic Upload Specification Tables 6,000 12 5/60
Registered Nurse (Infection Preventionist) 57.125 Central Line Insertion Practices Adherence Monitoring 100 100 25/60
Registered Nurse (Infection Preventionist) 57.126 MDRO or CDI Infection Form 6,000 72 30/60
Registered Nurse (Infection Preventionist) 57.127 MDRO and CDI Prevention Process and Outcome Measures Monthly Monitoring 6,000 24 15/60
Registered Nurse (Infection Preventionist) 57.128 Laboratory-identified MDRO or CDI Event 6,000 240 20/60
Registered Nurse (Infection Preventionist) 57.129 Adult Sepsis 50 250 25/60
Registered Nurse (Infection Preventionist) 57.137 Long-Term Care Facility Component—Annual Facility Survey 2,600 1 2
Registered Nurse (Infection Preventionist) 57.138 Laboratory-identified MDRO or CDI Event for LTCF 2,600 12 15/60
Registered Nurse (Infection Preventionist) 57.139 MDRO and CDI Prevention Process Measures Monthly Monitoring for LTCF 2,600 12 10/60
Registered Nurse (Infection Preventionist) 57.140 Urinary Tract Infection (UTI) for LTCF 2,600 14 30/60
Registered Nurse (Infection Preventionist) 57.141 Monthly Reporting Plan for LTCF 2,600 12 5/60
Registered Nurse (Infection Preventionist) 57.142 Denominators for LTCF Locations 2,600 12 4
Registered Nurse (Infection Preventionist) 57.143 Prevention Process Measures Monthly Monitoring for LTCF 2,600 12 5/60
Registered Nurse (Infection Preventionist) 57.150 LTAC Annual Survey 400 1 55/60
Registered Nurse (Infection Preventionist) 57.151 Rehab Annual Survey 1,000 1 55/60
Occupational Health RN/Specialist 57.200 Healthcare Personnel Safety Component Annual Facility Survey 50 1 8
Occupational Health RN/Specialist 57.203 Healthcare Personnel Safety Monthly Reporting Plan 17,000 1 5/60
Occupational Health RN/Specialist 57.204 Healthcare Worker Demographic Data 50 200 20/60
Occupational Health RN/Specialist 57.205 Exposure to Blood/Body Fluids 50 50 1
Occupational Health RN/Specialist 57.206 Healthcare Worker Prophylaxis/Treatment 50 30 15/60
Laboratory Technician 57.207 Follow-Up Laboratory Testing 50 50 15/60
Occupational Health RN/Specialist 57.210 Healthcare Worker Prophylaxis/Treatment-Influenza 50 50 10/60
Medical/Clinical Laboratory Technologist 57.300 Hemovigilance Module Annual Survey 500 1 2
Medical/Clinical Laboratory Technologist 57.301 Hemovigilance Module Monthly Reporting Plan 500 12 1/60
Medical/Clinical Laboratory Technologist 57.303 Hemovigilance Module Monthly Reporting Denominators 500 12 1.17
Medical/Clinical Laboratory Technologist 57.305 Hemovigilance Incident 500 10 10/60
Medical/Clinical Laboratory Technologist 57.306 Hemovigilance Module Annual Survey—Non-acute care facility 200 1 35/60
Medical/Clinical Laboratory Technologist 57.307 Hemovigilance Adverse Reaction—Acute Hemolytic Transfusion Reaction 500 4 20/60
Medical/Clinical Laboratory Technologist 57.308 Hemovigilance Adverse Reaction—Allergic Transfusion Reaction 500 4 20/60
Medical/Clinical Laboratory Technologist 57.309 Hemovigilance Adverse Reaction—Delayed Hemolytic Transfusion Reaction 500 1 20/60
Medical/Clinical Laboratory Technologist 57.310 Hemovigilance Adverse Reaction—Delayed Serologic Transfusion Reaction 500 2 20/60
Medical/Clinical Laboratory Technologist 57.311 Hemovigilance Adverse Reaction—Febrile Non-hemolytic Transfusion Reaction 500 4 20/60
Medical/Clinical Laboratory Technologist 57.312 Hemovigilance Adverse Reaction—Hypotensive Transfusion Reaction 500 1 20/60
Medical/Clinical Laboratory Technologist 57.313 Hemovigilance Adverse Reaction—Infection 500 1 20/60
Medical/Clinical Laboratory Technologist 57.314 Hemovigilance Adverse Reaction—Post Transfusion Purpura 500 1 20/60
Medical/Clinical Laboratory Technologist 57.315 Hemovigilance Adverse Reaction—Transfusion Associated Dyspnea 500 1 20/60
Medical/Clinical Laboratory Technologist 57.316 Hemovigilance Adverse Reaction—Transfusion Associated Graft vs. Host Disease 500 1 20/60
Medical/Clinical Laboratory Technologist 57.317 Hemovigilance Adverse Reaction—Transfusion Related Acute Lung Injury 500 1 20/60
Medical/Clinical Laboratory Technologist 57.318 Hemovigilance Adverse Reaction—Transfusion Associated Circulatory Overload 500 2 20/60
Medical/Clinical Laboratory Technologist 57.319 Hemovigilance Adverse Reaction—Unknown Transfusion Reaction 500 1 20/60
Medical/Clinical Laboratory Technologist 57.320 Hemovigilance Adverse Reaction—Other Transfusion Reaction 500 1 20/60
Medical/Clinical Laboratory Technologist 57.400 Patient Safety Component—Annual Facility Survey 5,000 1 5/60
Staff RN 57.401 Outpatient Procedure Component—Monthly Reporting Plan 5,000 12 15/60
Staff RN 57.402 Outpatient Procedure Component—Same Day Outcome Measures & Prophylactic Intravenous (IV) Antibiotic Timing Event 5,000 25 40/60
Staff RN 57.403 Outpatient Procedure Component—Monthly Denominators for Same Day Outcome Measures & Prophylactic Intravenous (IV) Antibiotic Timing Event 5,000 12 40/60
Staff RN 57.404 Outpatient Procedure Component—Annual Facility Survey 5,000 540 10/60
Registered Nurse (Infection Preventionist) 57.405 Outpatient Procedure Component—Surgical Site (SSI) Event 5,000 36 35/60
Staff RN 57.500 Outpatient Dialysis Center Practices Survey 7,000 1 2.0
Registered Nurse (Infection Preventionist) 57.501 Dialysis Monthly Reporting Plan 7,000 12 5/60
Staff RN 57.502 Dialysis Event 7,000 60 25/60
Staff RN 57.503 Denominator for Outpatient Dialysis 7,000 12 10/60
Staff RN 57.504 Prevention Process Measures Monthly Monitoring for Dialysis 2,000 12 1.25
Staff RN 57.505 Dialysis Patient Influenza Vaccination 325 75 10/60
Staff RN 57.506 Dialysis Patient Influenza Vaccination Denominator 325 5 10/60
Staff RN 57.507 Home Dialysis Center Practices Survey 350 1 30/60

Leroy A. Richardson,

Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention.

[FR Doc. 2017-20009 Filed 9-19-17; 8:45 am]

BILLING CODE 4163-18-P